Key facts
- This page summarizes Andreas Opfermann's Form 4 filing for LINDE PLC (LIN).
- 2 reported transactions and 9 derivative rows are listed below.
- Accepted by SEC: 09 Mar 2022, 14:23.
Andreas Opfermann - 07 Mar 2022 Form 4 Insider Report for LINDE PLC (LIN)
- Reporting relationship
- Executive VP
- Issuer ticker
- LIN
- Reported as of
- 07 Mar 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Mar 2022, 14:23:03 UTC
- Prior SEC filing
- 10 Jun 2021
- Next SEC filing
- 23 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- Anthony M. Pepper, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Andreas Opfermann filed Form 4 for LINDE PLC (LIN) on 09 Mar 2022.
Change
- Previous filing in this sequence was filed on 10 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LIN
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 546
- Date
- 07 Mar 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LIN
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +1,365
- Change %
- Price
- $0.000000
- Shares after
- 1,365
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 1,365
- Exercise price
- $0.000000
- Footnotes
- F1
LIN
transaction
Derivative
Stock Options (right to buy)
Award
- Transaction value
- $0
- Shares
- +11,830
- Change %
- Price
- $0.000000
- Shares after
- 11,830
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 11,830
- Exercise price
- $270.99
- Footnotes
- F5
LIN
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,810
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 1,810
- Exercise price
- $0.000000
- Footnotes
- F2
LIN
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,145
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 2,145
- Exercise price
- $0.000000
- Footnotes
- F3
LIN
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 320
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 320
- Exercise price
- $0.000000
- Footnotes
- F4
LIN
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 19,070
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 19,070
- Exercise price
- $253.68
- Footnotes
- F6
LIN
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 26,090
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 26,090
- Exercise price
- $173.13
- Footnotes
- F7
LIN
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 387
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 387
- Exercise price
- $1.92
- Footnotes
- F8
LIN
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,600
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 3,600
- Exercise price
- $176.63
- Footnotes
- F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.
Footnote F2
Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis.
Footnote F3
Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis.
Footnote F4
Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shaes on a one-for-one basis.
Footnote F5
This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
Footnote F6
This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
Footnote F7
This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
Footnote F8
Stock options have been granted pursuant to the Business Combination Agreement among Praxair, Inc., Linde AG, Linde plc and certain of their affiliates, dated June 1, 2017, as amended (the "BCA"). The stock options replace certain previously granted equity awards granted by Linde AG that were terminated in connection with the closing of the Business Combination of Praxair, Inc. and Linde AG that occurred on October 31, 2018. A more detailed explanation of these stock option replacement awards is discussed in the Linde plc Registration Statement on Form S-4 (Amendment No. 4) filed with the SEC on August 11, 2017 under the section titled "The Business Combination - Interests of Directors, Board Members and Executive Officers in the Business Combination - Linde AG - Treatment of Equity Awards" on pages 183-187.
Footnote F9
This option vests over three years in three consecutive equal annual installments beginning on March 20,2020.